ArticleCureus2025
Determinants of Delayed Breast Cancer Diagnosis: A Sample From the Mohammed VI Center for Cancer Treatment, Morocco.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA delayed diagnosis of breast cancer (BC) is linked to more advanced stages of the disease and lower survival rates. This study aims to explore the association between personal factors, family and community interactions, awareness of BC and breast self-examination (BSE), and delays in BC diagnosis among patients at the Mohammed VI Oncology Center, Casablanca, Morocco.
methodsWe conducted a cross-sectional study at the Mohammed IV Oncology Center from January 2023 to July 2024. A questionnaire was administered to collect data on sociodemographic and clinical characteristics of participants, personal factors, and community and family interactions, as well as their knowledge about BC and BSE practices. BC stages I and IIa were categorized as "early diagnosis," while stages IIb, IIIa, IIIb, and IV were classified as "delayed diagnosis." A time interval of more than three months was considered delayed. The chi-square test or Fisher's exact test was employed to assess the association between independent variables and outcomes. To examine the impact of the included factors on the interval of time (<3 months or >3 months), binary logistic regression analyses were conducted. Variables achieving statistical significance (p < 0.05) were subsequently included in the final multiple logistic regression models for each outcome.
resultsA total of 436 patients were interviewed, with a majority (65.1%) diagnosed at an advanced stage. The main factors impacting diagnosis interval included the individual's residency in rural or semi-urban areas (OR: 2.01, 95% CI: 1.01-4.00), fear of death (OR: 0.97, 95% CI: 0.95-0.99), fear of total mastectomy (OR: 5.44, 95% CI: 1.39-21.32), distrust in the expertise of institutions (OR: 9.07, 95% CI: 1.52-53.88), and having never heard of BC (OR: 4.79, 95% CI: 1.49-15.41). Conversely, performing BSE (OR: 0.35, 95% CI: 0.12-1.01) was identified as a significant protective factor against delayed diagnosis.
conclusionIt is crucial to focus on enhancing access to affordable, high-quality healthcare and to promote health literacy related to BC among the general public.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.